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Background
Statistical data resulted from the analysis of the cases
diagnosed and treated in the ICU of INBI Matei Balş in
the last 5 years. The continuous escalation of the technical
means of advanced life support associated to the anti-
bacterial and antifungal therapy required by the proven or
presumed etiology.
Methods
We analyzed risk factors, comorbidities, previous mainte-
nance treatment schemes, a complete picture of maximal
complexity which requires interdisciplinary teams.
Results
Statistical analysis of the data from the last 10 months
showed a total of 186 cases of sepsis, out of which
86 cases of severe sepsis and septic shock with a very
high rate of mortality (76 patients). Risk factors and
comorbidities (a high rate of obesity, cardiac diseases,
diabetes and immunodeficiency, elder patients (63.6 years
old), and so on) with etiology ranging from MDR GNB
(P. aeruginosa, A. baumannii, K. pneumoniae, Enterobacter
spp) to gram positive cocci, C. difficile, fungal infections,
and various viral infections (Influenza v., Parainfluenza,
Enteroviruses and even Hantavirus) could explain the
difficulties in the management of critically ill patients.
Conclusion
The comparative analysis with the previous years high-
lights the difficulties in the strategy of patient care in the
ICU. Under the prescribed medication schemes there were
both successes and failures, often due to the antibiotic
resistance profile. The ICU cases are more and more
complex, requiring the continuous optimization of the
therapy schemes, advanced ICU technology, and the
presence of a permanent multidisciplinary team, in the
hope of achieving a better severe sepsis control.
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